AMOXICILLIN CAPSULE

Pays: Canada

Langue: anglais

Source: Health Canada

Ingrédients actifs:

AMOXICILLIN (AMOXICILLIN TRIHYDRATE)

Disponible depuis:

SANIS HEALTH INC

Code ATC:

J01CA04

DCI (Dénomination commune internationale):

AMOXICILLIN

Dosage:

250MG

forme pharmaceutique:

CAPSULE

Composition:

AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250MG

Mode d'administration:

ORAL

Unités en paquet:

100/1000

Type d'ordonnance:

Prescription

Domaine thérapeutique:

AMINOPENICILLINS

Descriptif du produit:

Active ingredient group (AIG) number: 0131314001; AHFS:

Statut de autorisation:

APPROVED

Date de l'autorisation:

2010-11-02

Résumé des caractéristiques du produit

1
PRODUCT MONOGRAPH
PR AMOXICILLIN
AMOXICILLIN CAPSULES, USP
250 MG AND 500 MG AMOXICILLIN (AS AMOXICILLIN TRIHYDRATE)
AMOXICILLIN GRANULES FOR ORAL SUSPENSION, USP
250 MG/5 ML AMOXICILLIN (AS AMOXICILLIN TRIHYDRATE) AFTER
RECONSTITUTION
AMOXICILLIN SUGAR-REDUCED GRANULES FOR ORAL
SUSPENSION, MANUFACTURER’S STANDARD
250 MG/5 ML AMOXICILLIN (AS AMOXICILLIN TRIHYDRATE) AFTER
RECONSTITUTION
Antibiotic
Sanis Health Inc.
Date of Revision:
1 President’s Choice Circle
June 18, 2020
Brampton, Ontario
L6Y 5S5
www.sanis.com
Control No. 239798
2
NAME OF DRUG
AMOXICILLIN
(AMOXICILLIN TRIHYDRATE)
THERAPEUTIC CLASSIFICATION
Antibiotic
ACTION AND CLINICAL PHARMACOLOGY
AMOXICILLIN (amoxicillin) exerts its bactericidal action by
interfering with bacterial
cell wall synthesis.
INDICATIONS AND CLINICAL USE
AMOXICILLIN (amoxicillin) may be indicated in the treatment of
infections due to
susceptible strains of the following micro-organisms: Gram-negative
organisms: H.
influenzae, P. mirabilis and N. gonorrhoeae. Gram-positive organisms:
Streptococci
(including Streptococcus faecalis and Streptococcus pneumoniae).
Amoxicillin is not active against Pseudomonas aeruginosa,
indole-positive Proteus
species, Serratia marcescens, Klebsiella and Enterobacter species.
In emergency cases, where the causative organism is not yet
identified, therapy may be
initiated with amoxicillin on the basis of clinical judgment while
awaiting bacteriologic
tests to determine its antimicrobial sensitivity.
AMOXICILLIN may be indicated as a prophylaxis against alpha-hemolytic
(Viridan's
group) Streptococci before dental, oral or upper respiratory tract
surgery or
instrumentation.
It may be also indicated as a prophylaxis of bacterial endocarditis in
patients with any of
the following conditions: congenital cardiac malformations, rheumatic
and other acquired
valvular lesions, prosthetic heart valves, previous history of
bacterial endocarditis,
hypertrophic cardiomyopathy, surgically constructed systemic pulmonary
shunts, mitral
valve prolapse with valvular